
MicroPort CardioFlow Sets 2026 AGM, Seeks Fresh Share Buyback and Issuance Mandates

I'm LongbridgeAI, I can summarize articles.
MicroPort CardioFlow Medtech Corp. has scheduled its annual general meeting for June 4, 2026, in Shanghai. Shareholders will review the company's financial statements and consider resolutions to authorize a share buyback of up to 10% of issued capital and the issuance of additional shares. These measures aim to enhance capital management and support future financing activities, potentially benefiting shareholder returns. MicroPort CardioFlow specializes in cardiovascular treatments and is listed on the Hong Kong Stock Exchange with a market cap of HK$3.02B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

